XPO Opens Three New Service Centers in Growing Freight Markets to Enhance Service for Customers
GREENWICH, Conn. , April 10, 2024 (GLOBE NEWSWIRE) — XPO (NYSE: XPO), a leading provider of LTL freight transportation in […]
Monopar Initiates Radiopharma Phase 1 Clinical Trial for MNPR-101-Zr in Advanced Cancer Patients
WILMETTE, Ill., April 10, 2024 (GLOBE NEWSWIRE) — Monopar Therapeutics Inc. (Nasdaq: MNPR), a clinical-stage biopharmaceutical company focused on developing innovative […]
Abcourt Provides an Operational Update at Its Sleeping Giant Mine
ROUYN-NORANDA, Quebec, April 10, 2024 (GLOBE NEWSWIRE) — Abcourt Mines Inc. (“Abcourt” or the “Company”) (TSX Venture: ABI) is pleased […]
Northann Corp Announces Cross-Licensing Agreement with I4F for Digital Printing Technology
ELK GROVE, Calif., April 10, 2024 (GLOBE NEWSWIRE) — Northann Corp. (NYSE American: NCL), a leading innovator in 3D-printed home […]
Dayforce to Announce First Quarter 2024 Financial Results on May 1st and Present at Upcoming Investor Conferences
TORONTO and MINNEAPOLIS, April 10, 2024 (GLOBE NEWSWIRE) — Dayforce, Inc. (NYSE:DAY) (TSX:DAY), a global leader in human capital management […]
Lancaster Resources Acquires Piney Lake Gold Property
VANCOUVER, British Columbia, April 10, 2024 (GLOBE NEWSWIRE) — Lancaster Resources Inc. (CSE:LCR | OTCQB:LANRF | FRA:6UF0) (“Lancaster” or the […]
Sunrun Prices $230 million Senior Securitization of Residential Solar & Battery Systems
SAN FRANCISCO, April 10, 2024 (GLOBE NEWSWIRE) — Sunrun (Nasdaq: RUN), the nation’s leading provider of clean energy as a […]
Ikena Oncology to Present at the Stifel 2024 Virtual Targeted Oncology Forum
BOSTON, April 10, 2024 (GLOBE NEWSWIRE) — Ikena Oncology, Inc. (Nasdaq: IKNA, “Ikena,” “Company”), a targeted oncology company forging new […]
Daxor Corporation Announces New Hospital Account at Leading Chicago Hospital
450-Bed Hospital Purchases BVA-100™Blood Volume Analyzer to Launch Heart Failure Program Oak Ridge, TN, April 10, 2024 (GLOBE NEWSWIRE) — […]
Qualigen Therapeutics’ Novel Direct Pan-RAS Inhibitors Presented at American Association of Cancer Research (AACR) 2024 Annual Meeting
Poster Includes Preclinical Data on Novel Direct Pan-RAS Inhibitors CARLSBAD, Calif., April 10, 2024 (GLOBE NEWSWIRE) — Qualigen Therapeutics, Inc. (“Qualigen” […]
